ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 238

Identifying Immunoglobulin G4-Related Disease in Archived Pathological Specimens

Priya Prakash1, Faisal Saeed2, Slavica Bobic3, Kirk Sperber1, Julia Yegudin-Ash1, Humayun Islam2 and Amy Wasserman4, 1Medicine-Rheumatology, New York Medical College / Westchester Medical Center, Valhalla, NY, 2Pathology, New York Medical College / Westchester Medical Center, VALHALLA, NY, 3Medicine-Rheumatology, New York Medical College / Westchester Medical Center, valhalla, NY, 4Medicine - Rheumatology, New York Medical College / Westchester Medical Center, VALHALLA, NY

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: IgG4 Related Disease, Retroperitoneal Fibrosing and sialoadenitis

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 13, 2016

Title: Miscellaneous Rheumatic and Inflammatory Diseases - Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Immunoglobulin G4-related disease (IgG4-RD) is a recently defined entity characterized by a diffuse or mass forming inflammatory reaction rich in IgG4-positive plasma cells.  Due to the fact that IgG4-RD was only fully described in the past decade, the epidemiology and prevalence of this disease is still not understood. It is likely that many pathology specimens prior to this time period were not recognized as IgG4-RD.The purpose of this study is to identify IgG4-RD in a by retrieving archived pathological slides originally diagnosed as idiopathic sclerosing masses, fibrosis or chronic inflammation in our tertiary care center.

Methods: This is a retrospective review of archived pathological slides at Westchester Medical Center from the years 2005-2015.We initially retrieved 105 cases using various search criteria from the Pathology database. Of these, 23 cases were included in this study, which fulfilled our final inclusion criteria of biopsy-proven idiopathic sclerosing masses, fibrosis and/or chronic inflammation. Immunohistochemical stains were performed on these specimens including IgG4. In this study we defined IgG4–RD as immunohistochemistry (IHC) > 10 IgG4+ plasma cells/ HPF and IgG4+/IgG ratio>40%, as well as the presence of characteristic histopathology architecture (dense lymphoplasmacytic infiltrate, storiform fibrosis and obliterative phlebitis) 1,2. Other epidemiological data obtained were age, gender, organ involved and original tissue pathology diagnosis.  

Results: Thirty-four percent of the biopsies (n=8/23) were reclassified as IgG4-RD.  The most common original histological diagnosis for the eight reclassified specimens was chronic sialadenitis (Table Image) with submandibular gland most frequently involved, followed by parotid gland and retroperitoneal mass. The reclassified specimens were more common in females (5/8) and those above ages 60 (5/8).

Conclusion: This is the only known reported retrospective review study of archived pathological slides for IgG4-RD. The results highlight the ability to reconsider diagnosis, if needed, by performing appropriate immunohistochemical analysis on archived specimens to identify IgG4-RD. Chronic sialadenitis was the most common mimicker of IgG4-RD. Reference : 1. Deshpande V, et al. Consensus statement on the pathology of the IgG4-related disease. Modern Pathol. 2012; 25:1181–92 2. Khosroshahi A, et al. International Consensus Guidance Statement on the Management and Treatment of IgG4-Related Disease. Arthritis & Rheumatology, 2015; 67: 1688–1699.


Disclosure: P. Prakash, None; F. Saeed, None; S. Bobic, None; K. Sperber, None; J. Yegudin-Ash, None; H. Islam, None; A. Wasserman, None.

To cite this abstract in AMA style:

Prakash P, Saeed F, Bobic S, Sperber K, Yegudin-Ash J, Islam H, Wasserman A. Identifying Immunoglobulin G4-Related Disease in Archived Pathological Specimens [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/identifying-immunoglobulin-g4-related-disease-in-archived-pathological-specimens/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/identifying-immunoglobulin-g4-related-disease-in-archived-pathological-specimens/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology